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Macrophages Control the Retention and Trafficking of
B Lymphocytes in the Splenic Marginal Zone
Mikael C.I. Karlsson,1 Rodolphe Guinamard,1, 3 Silvia Bolland,1, 4
Marko Sankala,5 Ralph M. Steinman,2 and Jeffrey V. Ravetch1

Abstract
The marginal zone of the spleen is a precisely ordered region that contains specialized subsets of
B lymphocytes and macrophages. Disruption of the negative signaling inositol phosphatase,
SH2-containing inositol-5-phosphatase 1 (SHIP), results in the loss of marginal zone B cells
(MZBs) with reorganization of marginal zone macrophages (MZMOs) to the red pulp of the
spleen. This primary macrophage defect, as revealed by selectively depleting SHIP in myeloid
cells shows that MZMOs are specifically required for the retention of MZBs. The MZMO
phenotype was reverted in SHIP/Bruton’s tyrosine kinase (Btk) double knockout mice, thus
identifying the Btk activating pathway as an essential component being regulated by SHIP.
Furthermore, we identified a direct interaction between the MARCO scavenger receptor on
MZMOs and MZBs. Activation or disruption of this interaction results in MZB migration to
the follicle. The migration of the MZMOs was further studied after the response to Staphylococcus
aureus, which induced MZMOs to move into the red pulp while MZBs migrated into the
follicular zone. The marginal zone is therefore a dynamic structure in which retention and
trafficking of B cells requires specific macrophage–B cell interactions.
Key words: SHIP • Btk • MARCO • migration • Staphylococcus aureus

Introduction
Blood-borne pathogens first encounter the adaptive immune
system in the marginal zone region of the spleen where the
convergence of innate and adaptive immune mechanisms
insures an early and effective response to pathogen antigens
(1, 2). Both thymic-independent and -dependent responses
are elicited in response to infection (1, 3). The thymicindependent response involves the targeting and activation
of marginal zone B cells (MZBs)* through their interaction
with the repetitive antigenic determinants of pathogens
with complement and B cell antigen receptors (4, 5). In
Address correspondence to Jeffrey V. Ravetch, Laboratory of Molecular
Genetics and Immunology, The Rockefeller University, Box 98, 1230
York Avenue, New York, NY 10021. Phone: 212-327-7321; Fax: 212327-7318; E-mail: ravetch@rockefeller.edu
*Abbreviations used in this paper: Btk, Bruton’s tyrosine kinase; ES, embryonic stem; MZB, marginal zone B cell; MZMO, marginal zone macrophage; SHIP, SH2-containing inositol-5-phosphatase 1.

333

contrast, the thymic-dependent Ab response is driven by
the interaction and reciprocal stimulation of APCs, T lymphocytes, and B cells. The organization of the splenic white
pulp nodule into discrete zones enriched for either B cells,
T cells, or APCs provide a spatial microenvironment that
facilitates an efficient interaction of pathogens with the various cellular populations required for insuring an efficient
immune response (6–8). Antigen presentation and stimulation of T and B cells ultimately results in the formation of
germinal centers, high affinity neutralizing Abs, and memory cells. Recent reports have begun to define the cellular
components and molecular signals that are necessary to establish the marginal zone. B cell intrinsic pathways have
been described involving specific chemokines and their receptors, molecules involved in B cell activation, as well as
adhesion molecules and their ligands (9, 10). Apart from
the MZB, the other predominant cell of the marginal zone
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anti-FITC and anti-biotin beads were from Miltenyi Biotec.
Cl2MDP (or clodronate) and PBS liposomes were provided by
Roche Diagnostics.
Conditional Targeting of SHIP. Floxed SHIP mice were created by insertion of loxP sites flanking the 10th and 11th exons
(see Fig. 2 a) of the SHIP gene. The targeting vector was introduced into embryonic stem (ES) cells by electroporation and
clones were selected with neomycin and ganciclovir and verified
by Southern blot and PCR. Properly integrated ES clones were
transiently transfected with a Cre-expressing plasmid. Clones
were subsequently selected for a conditional floxed allele (SHIPflox)
or null allele (SHIPnull) using Southern blot and PCR. Appropriate ES clones were then injected into blastocysts to generate
chimeric mice. The chimeric mice were then bred with C57BL/6
mice to achieve germline transmission. These mice were subsequently crossed with mice expressing Cre in the myeloid compartment (LysMcre; reference 19) to generate Cre/null/flox
mice. Mice were screened for respective genotype by PCR and
SHIP protein expression using Western blot (21) on equal numbers of spleen cells purified by MACS (Miltenyi Biotec) sorting

Materials and Methods
Mice. C57BL/6 mice obtained from The Jackson Laboratory
were used as WT mice and controls unless otherwise stated.
Founders of SHIP-deficient mice were provided by G. Krystal
(Terry Fox Laboratory, BC Cancer Agency, Vancouver, Canada;
reference 18) and Btk-deficient mice were purchased from The
Jackson Laboratory. Op/op mice were provided by J. Pollard
(Albert Einstein College of Medicine, New York, NY) and
LysMCre transgenic mice (19) were provided by I. Forster
(Technical University of Munich, Germany). Abs and bacteria
was injected i.v. in the tail vein and all experiments involving
mice were performed in accordance with National Institutes of
Health (NIH) guidelines. All mice were maintained under specific pathogen-free conditions at The Rockefeller University.
Antibodies and Reagents. For histological examination 6-M
frozen sections were stained, and for FACS® analysis erythrocytedepleted spleen cells were used. Macrophages were detected using MOMA-1, MARCO Abs from Serotec, and ER-TR9 from
Accurate Chemical & Scientific Corp. Abs to CD1d, B220,
CD19, CD21/CD35 (CRI/II), CD23, MAC-1, anti–rat alkaline
phosphatase, and anti–rabbit horseradish peroxidase were from
BD Biosciences. Secondary Abs for immunohistochemistry, antibiotin, anti-FITC F(ab) horseradish peroxidase, or alkaline phosphatase were from DakoCytomation and rabbit anti–SHIP used
for Western blot was from Upstate Biotechnology. Vector Blue
Alkaline Phosphatase Substrate from Vector Laboratories and
DAB peroxidase substrate from Sigma-Aldrich were used for development of immunohistochemistry stains. Soluble MARCO
receptor was provided by T. Pikkarainen (The Karolinska Institute, Stockholm, Sweden; reference 20) and was biotinylated
using the EZ-Link™ kit from Pierce Chemical Co. The biotinylated soluble MARCO was detected using StreptavidinCyChrome™ from BD Biosciences. S. aureus fluorescent bioparticles were purchased from Molecular Probes, Inc. and MACS
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Figure 1. SHIP-deficient mice lack MZBs and MZMOs are displaced
to the red pulp. (a) FACS® profiles of single cell suspensions from the
spleen of SHIP-heterozygous (SHIP/) and -deficient (SHIP/) mice.
MZBs were measured as the CD19, CRIhigh, and CD23low population.
The numbers shown represent percent of CD19 cells for the depicted
gates as an average of five mice. Numbers for the follicular B cells are
shown for comparison. (b) Representative immunohistochemical analysis
of above listed mice. At least four serial sections from each mouse were
stained for MOMA-1 (blue, top) metallophilic macrophages or
MARCO MZMOs (blue, bottom). Sections were also stained for B220
(brown) to show the positioning of the follicle. 10.
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is the marginal zone macrophage (MZMO), which is distinct from the metallophilic macrophage, defined by the
marker MOMA-1, located at the border of the marginal
and follicular zone (11). The MZMO is defined by its location, interspersed in several layers within the marginal
zone, and by its expression of the markers MARCO and
ER-TR9 (12, 13). The former molecule is a scavenger receptor belonging structurally to the class A receptor family
whereas the latter is identical to the C-type lectin SIGNRI (14–17). MARCO has been shown to bind a range of
microbial Ags including Staphylococcus aureus and Escherichia
coli whereas SIGN-RI is the predominant receptor for uptake of polysaccharide dextran by MZMOs. Even though
both MZBs and MZMOs are implicated in both thymusdependent and -independent immune responses, the exact
roles of the two cell types in initiation of the response to
blood-borne pathogens is not known. We now define a
unique role for the MZMO in regulation of MZB retention and activation and show that movement of this subset
of macrophages to the red pulp of the spleen involves signaling via SH2-containing inositol-5-phosphatase 1 (SHIP)
and Bruton’s tyrosine kinase (Btk). In addition, we show a
direct interaction between MZMOs and MZBs via the
MARCO receptor on MZMOs and a ligand on MZBs.

according to protocol from the manufacturer. Relative expression
of SHIP in macrophage and B cell populations (comparing wt/
null with flox/null/cre) were estimated using Alpha imager software from Alpha Innotech Corp.

Mice deficient in the inhibitory signaling molecule SHIP
display pleiotropic defects in macrophages, NK cells, and
lymphocytes (18, 22). A prominent feature of these mice is
their splenomegaly resulting from dysregulation of myeloid
proliferation. As seen in Fig. 1, SHIP-deficient mice also
display a specific defect in the organization of the splenic
follicle with the loss of MZBs measured as the CD21high/
CD23low population in FACS® and in sections as the B220
cells localizing peripherally to the MOMA-1 cells (Fig. 1,
a and b). In the SHIP-deficient mice the MARCO
MZMO cells are no longer organized within the marginal
zone and adjacent to the MOMA-1 macrophages but are
redistributed to the red pulp, whereas MOMA-1 metallophils remain unaffected (Fig. 1 b). Because SHIP is expressed in most hematopoietic cells, including lymphoid
and myeloid subsets, we determined if this marginal zone
phenotype in SHIP-deficient mice was the result of primary macrophage dysregulation. A conditional disruption
of SHIP was generated in which macrophages displayed an
approximate 90% reduction in SHIP expression whereas

Figure 2. Conditional targeting of SHIP in macrophages results in MZMO displacement and reduced
numbers of MZBs. (a) A targeting construct covering
exons 10 to 13 of SHIP, from EcoRI (E) to HindIII
(H), was made. Boxes represent exons and triangles
represent loxP sites flanking exons 10 to 11 and a neomycin resistance gene (neo). Properly integrated ES
cell clones were transiently transfected with Cre recombinase to create conditional floxed (SHIPflox) or
null (SHIPnull) clones. These cells were subsequently
used to create floxed (flox) and null mice, which were
crossed to mice expressing Cre from a macrophagespecific lysosomal promoter (cre). (b) Western blot
analysis of MAC1 and CD19 spleen cells (SPC) from
WT, WT/null, null/null, LysM floxed (flox/null/cre),
and relative spleen size of 6-wk-old WT/null and flox/
null/cre SHIP mice. (c) FACS® and histological profiles of single cell suspensions from the spleen of the
conditionally targeted SHIP KO mice. MZBs were
measured as the CD19, CRIhigh, and CD23low population. The numbers shown represent percent of CD19
cells for the depicted gates as an average of five mice
and the numbers for the follicular B cells are shown for
comparison. For representative immunohistochemical
analysis, at least four serial sections were stained for
MOMA-1 (blue, top) metallophilic macrophages or
MARCO MZMOs (blue, bottom). Sections were
also stained for B220 (brown) to show the positioning
of the follicle. Refer to Fig. 1 for SHIP  and SHIP 
profiles. 10.
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Results and Discussion

B cell expression was reduced by 10% (Fig. 2, a and b).
This is consistent with the expression patterns of Cre recombinase, driven by the lysosyme promoter used (19).
The mice developed a splenomegaly at 5 wk of age (Fig.
2 b), similar to that of complete SHIP deletion, thus implicating a primary macrophage defect as the cause for splenomegaly in SHIP  mice (18). In addition, the mice displayed essentially the same marginal zone phenotype with
significantly reduced MZBs as defined by flow cytometry
and reorganization of the MZMOs as observed by histological staining (Fig. 2 c). To confirm that the SHIP phenotype is B cell nonautonomous and that SHIP-deficient B
cells can give rise to MZB populations when WT MZMOs
are available, we produced BM chimeras using SHIP-deficient BM combined with WT BM and injected these cells
into irradiated WT recipients. In the resulting chimeric
mice the SHIP-deficient and WT BMs contributed equally
to the MZB population (unpublished data).
In B cell lines it has been shown that SHIP functions as a
negative regulator of cellular activation by regulating the
association of the positive signaling kinase Btk with the
membrane, thus raising the threshold required for stimulation (23). It does so by hydrolyzing PIP3, the substrate for
Btk association with the membrane, thereby reducing the
ability of Btk to become membrane associated and activated (24). Because both SHIP and Btk are expressed in

The Journal of Experimental Medicine

macrophages and a link between these molecules had been
suggested, we reasoned that the myeloid proliferation and
MZMO phenotype leading to the loss of MZBs might be
the result of inappropriate activation of Btk in macrophages

Figure 4. MARCO MZMOs are required for retention of MZBs. Representative immunohistochemical analysis and
FACS® profiles of spleens from at least four
WT mice treated with liposomes or untreated op/op mice. WT mice were injected
i.v. with 100 l PBS containing liposomes
or with liposomes containing clodronate at a
1:24 dilution where MZMOs were preferentially depleted. 48 h later serial spleen
sections were stained for MOMA-1
(blue, top) metallophilic macrophages or
MARCO (blue, middle) MZMOs. The
sections were also stained for B220 (brown)
to see the positioning of these populations in
relation to the B cell follicle. 10. Spleen
cells were analyzed by FACS® analysis for
detection of MZBs as measured by the
CD19, CRIhigh, and CD23low population.
Numbers shown are the average percentpositive cells of four mice. Similar profiles
are shown for untreated op/op mice (right).
Data shown are representative of three independent experiments.
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Figure 3. SHIP and Btk interact in
myeloid proliferation and activation.
(a) FACS® and histological profiles of
single cell suspensions from the spleen
of SHIP and Btk double KO mice
(SHIP//Btk). MZBs were measured as the CD19, CRIhigh, and
CD23low population. The numbers
shown represent percent of CD19
cells for the depicted gates as an average of four mice and the numbers for
the follicular B cells are shown for
comparison. For representative immunohistochemical analysis, at least four
serial sections from were stained for
MOMA-1 (blue, top) metallophilic
macrophages or MARCO MZMOs
(blue, bottom). Sections were also
stained for B220 (brown) to show the
positioning of the follicle. 10. (b)
Relative spleen size of 5-wk-old heterozygous KO or double KO mice.

of SHIP-deficient animals (25, 26). Disruption of Btk in
macrophages may thus be sufficient to restore normal signaling thresholds in SHIP-deficient mice. Combining the
SHIP deficiency with a Btk deficiency resulted in the restoration of both the normal marginal zone structure (Fig. 3
a) and spleen size (Fig. 3 b) indicating that Btk is an important target of SHIP in myeloid cells in vivo. Similarly, Btk
deficiency counteracted the over responsiveness of myeloid
progenitors to GM-CSF and M-CSF in SHIP-deficient
mice (unpublished data). Both the dysregulation of myeloid
proliferation and follicular architecture likely result from
enhanced signaling through the Btk pathway in myeloid
cells. Reversion of the MZB and myeloid phenotypes in
SHIP  mice by deletion of Btk suggests that Btk is the
dominant Tec family member regulated by SHIP in these
cells. The observation that other members of the family are
expressed in macrophages and have been shown to be able
to substitute for Btk both in vivo and in KO mice indicates
a surprising degree of specificity to the SHIP inhibitory
pathway (27–29).
These results suggested that MZMOs might be critical to
the organization of the white pulp nodule and localization
of MZBs in this structure. To test this directly we exploited
the observation that MZMOs can be ablated by their preferential ingestion of macrophage-depleting liposomes (30).
At a low concentration of these liposomes we could see
preferential depletion of MARCO MZMOs as opposed
to the adjacent MOMA-1 macrophages (Fig. 4). Other
phagocytic cells in the spleen, such as red pulp macrophages
and dendritic cells were largely unaffected by this treatment

Figure 5. Soluble MARCO receptor (sMARCO) binds preferentially
to MZBs. Representative FACS® analysis of spleen cells from WT mice
stained with CRI, CD23, and biotinylated sMARCO. Binding of
sMARCO to different spleen cell populations was based on gates set on
the CRI versus CD23 stain. red, MZBs; blue, follicular B cells; black,
non-B cells. The histogram (bottom) shows the mean fluorescence index
(MFI) and SD (n 5) for the different populations as well as the avidin
(Av) control and block using the MARCO-specific ED31 Ab. Data
shown are representative of three independent experiments.

337

Karlsson et al.

The Journal of Experimental Medicine

structure in which MZBs, identified by CD1d staining,
were found in the follicular region whereas MZMOs,
identified by ER-TR9 staining, were retained in the
marginal zone (Fig. 6). These results suggest that a direct
interaction between MZMO and MZBs is mediated by
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(not depicted). When MZMOs were depleted in this fashion, we observe a specific reduction in the MZBs by both
flow cytometry and histological staining. In contrast,
MOMA-1 macrophages are specifically absent in the CSF1–deficient strain op/op but these mice retain MARCO/
ER-TR9 MZMOs (31, 32). The absence of the MOMA1 cells and the ER-TR9 marker did not result in reduction in MZBs, but rather, an expansion of these cells is observed, indicating that the macrophage population that is
required for MZB retention are the MARCO MZMOs.
The identity of the retention signal expressed by
MARCO MZMO cells was next determined by investigating the role of specific surface receptors on the MZMO
in maintaining the marginal zone structure. The MARCO
receptor, in addition to binding to bacteria (33), contains
an SRCR domain that has been implicated in binding to
CD19 lymphocytes (34, 35). To determine if MARCO
itself is capable of binding to MZBs, we expressed the extracellular domains of MARCO as a soluble molecule (20)
and used it to stain splenic populations (Fig. 5). Three populations of cells were distinguished by flow cytometry
when stained with CD21 and CD23. Maximal binding to
soluble MARCO was observed for the MZBs (CD21hi
CD23low), whereas the follicular B cells (CD21low CD23hi)
displayed reduced binding. None of the other splenic populations (T cells, macrophages, or dendritic cells) were capable of binding to soluble MARCO. This binding was
specific for the MARCO SRCR domain, as determined
by the ability of a monoclonal Ab to this domain (ED31;
reference 33) to block the binding of soluble MARCO to
MZBs. When the MARCO-specific Ab was injected i.v.
to WT mice it resulted in disruption of the marginal zone

Figure 6. In vivo disruption of MARCO and MZB interactions leads
to MZB migration to the follicle. WT mice were given 100 g control
rat IgG or anti-MARCO (ED31) IgG i.v. 3 h later the mice were killed
and the spleens were stained for macrophage and B cell populations. Representative stains of serial sections from at least four different mice are
shown. MZMOs were detected with anti-MARCO (blue, top) or
ER-TR9 (blue, middle) antibodies whereas metallophilic macrophages
were stained with MOMA-1 (brown, bottom). B220 B cells (brown)
were stained for positioning of the follicle and MZBs as the CD1high (blue,
bottom) population. 10. Part of the spleen was used for flow cytometric
analysis to determine the CD19, CRIhigh, and CD23low populations.
Numbers shown are the average of four mice. The percent of CD19
cells for either MZBs or follicular B cells is shown for comparison. Data
shown are representative of two independent experiments.
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MARCO–MZB binding, through a MARCO ligand expressed on these B cells, and provides a mechanism for the
retention of MZBs by MARCO-expressing MZMO cells.
Perturbation of this interaction either by disruption of adhesion and/or induction of macrophage activation by
MARCO cross-linking results in the appearance of cells
expressing a MZB surface phenotype in the follicular zone.
To address the relevance of the MARCO MZMO and
its retention of MZBs to its contribution to the development of an immune response to pathogens, we injected
mice i.v. with rhodamine-conjugated S. aureus, which is a
known ligand for the MARCO receptor (12). Within 30
min of injection bacteria were visualized exclusively bound
to the MZMO cells, a role consistent with the phagocytic
property of these scavenger receptor–expressing cells (Fig.
7). 18 h after injection the microbes and the MZMO were
found to have comigrated into the red pulp and cells with a
MZB phenotype (CD1dhigh) were mostly found in the follicular region. These results are consistent with a model in
which interaction of S. aureus with MARCO on MZMOs
results in their migration into the red pulp and the concomitant migration of MZBs into the follicular region as
has been reported for LPS and E. coli (8, 9). The deletion of
the inhibitory signaling molecule SHIP results in a similar
MZMO migration response, suggesting that MZMO activation can trigger migration into the red pulp. We presume
that the likely explanation for the migration seen in response to S. aureus ingestion is the activation of MZMOs
by their encounter with these bacteria as has been described
(36, 37). A similar result was observed for E. coli suggesting
a more general migratory response by MZMO cells to microbial challenge (unpublished data). The migratory response of the MZMO, carrying Ag to the red pulp, could
simply be a method of clearance of particulate Ags or alternatively MZMOs could function as Ag transporters/presenters and supporters of plasmablast formation shown to
338

take place in the red pulp (Fig. 8; references 38–40). This
has previously been reported to be a function of dendritic
cells in the T/B cell border of the follicle and by macrophages supporting B1 B cells in the peritoneum (10). Interestingly, Kang et al. (14) recently showed that phagosomes
in MZMOs, after uptake of dextran polysaccarides via
SIGN-RI did not stain positive for the endosomal markers
LAMP-1 and transferrin. This suggests that Ags taken up

Figure 8. Proposed model for interactions between MZMO and MZB
and the response of these cells to blood-borne pathogens. In the marginal
zone (MZ), MZBs interact with the MZMO via the MARCO receptor
(a) and with stromal elements via the ICAM/VCAM and their respective
ligands LFA-1 and 4 1 (b). Upon phagocytosis of particulate Ags, the
MARCO MZMOs migrate to the red pulp (c) and the majority of the
MZBs migrate to the follicle where they interact with cells such as dendritic and follicular dendritic (d, DC and FDC). In the early response to T
cell–independent Ags, the MZB also has the capacity to migrate to the
red pulp to take part in plasma cell formation (e), where a possible interaction with MZMOs and MZBs may take place.

Interaction between Marginal Zone Macrophages and B Cells

Downloaded from http://rupress.org/jem/article-pdf/198/2/333/990379/jem1982333.pdf by Rockefeller University user on 11 August 2020

Figure
7. S. aureus induce
MZMO movement and displacement of MZBs. WT mice were injected i.v. with 250 g heat-killed
and rhodamine-conjugated S. aureus
in PBS. 0.5 or 18 h later the mice
were killed and the spleens were sectioned and stained. Representative
stains from at least four mice are
shown. MARCO MZMOs (left)
are stained blue and B220 B cells
are stained brown. The middle
shows the same stains as in the left,
merged with the fluorescent stain of
S. aureus. The right shows stains for
the CD1high MZB population (blue)
and MOMA-1 metallophilic macrophages (brown). 10. The data
shown are representative of two independent experiments.

The Journal of Experimental Medicine
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